Interestingly, despite the high efficacy of anti–PD-1 blockade in relapsed/refractory CHL (17, , , , –22), PD-1+ cells are not particularly abundant in Hodgkin lymphoma (HL) tissue except in LR-CHL (15, 23). Here, PDCD1 is linked to classic Hodgkin lymphoma.